BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 402162)

  • 21. Erythrocyte based delivery system of primaquine: in vitro characterization.
    Talwar N; Jain NK
    J Microencapsul; 1992; 9(3):357-64. PubMed ID: 1403486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutaraldehyde fixation and the mechanism of erythroycte agglutination by concanavalin A and soybean agglutinin.
    Marquardt MD; Gordon JA
    Exp Cell Res; 1975 Mar; 91(2):310-6. PubMed ID: 805054
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the synthetic capacity and antigenic expression of glutaraldehyde-fixed target cells.
    Bubbers JE; Henney CS
    J Immunol; 1975 Mar; 114(3):1126-31. PubMed ID: 122990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of glutaraldehyde and osmium tetroxide on the erythrocyte membrane. A spin label study.
    Komorowska M; Koter M; Bartosz G; Gomułkiewicz J
    Biochim Biophys Acta; 1982 Mar; 686(1):94-8. PubMed ID: 6279155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement-induced modifications in membrane fluidity: studies with resealed and glutaraldehyde-treated erythrocyte membrane ghosts.
    Giavedoni EB; Mason RP; Dalmasso AP
    J Immunol; 1978 Jun; 120(6):2003-7. PubMed ID: 207778
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of cell contour analysis to evaluate the affinity between macrophages and glutaraldehyde-treated erythrocytes.
    Mege JL; Capo C; Benoliel AM; Bongrand P
    Biophys J; 1987 Aug; 52(2):177-86. PubMed ID: 3117125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutaraldehyde-treated carrier erythrocytes for organ targeting of methotrexate in dogs.
    DeLoach JR; Barton C
    Am J Vet Res; 1981 Nov; 42(11):1971-4. PubMed ID: 6802043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the actions of glutaraldehyde, formaldehyde, and mixtures of glutaraldehyde and formaldehyde on tissue proteins.
    Kirkeby S; Moe D
    Acta Histochem; 1986; 79(1):115-21. PubMed ID: 3090833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of treatment with glutaraldehyde and of storage in acid-citrate-dextrose solution on agglutinability of erythrocytes.
    Nishi K; Yamada M; Wakasugi C
    Nihon Hoigaku Zasshi; 1983 Dec; 37(6):757-63. PubMed ID: 6431157
    [No Abstract]   [Full Text] [Related]  

  • 30. The surface charge of human glutaraldehyde-fixed erythrocytes.
    Grunze M; Heuck CC
    Biochim Biophys Acta; 1986 Mar; 856(1):41-4. PubMed ID: 3082359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A method using toluene-2,4-diisocyanate and glutaraldehyde to stabilize and conjugate antigens to erythrocytes for use in passive hemagglutination tests.
    Mahan DE; Copeland RL
    J Immunol Methods; 1978; 19(2-3):217-25. PubMed ID: 203632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fixation with even small quantities of glutaraldehyde affects red blood cell surface properties in a cell- and species-dependent manner. Studies by cell partitioning.
    Walter H; Krob EJ
    Biosci Rep; 1989 Dec; 9(6):727-35. PubMed ID: 2482090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic properties of doxorubicin encapsulated in glutaraldehyde-treated canine erythrocytes.
    Tonetti M; Astroff AB; Satterfield W; De Flora A; Benatti U; DeLoach JR
    Am J Vet Res; 1991 Oct; 52(10):1630-5. PubMed ID: 1767983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response to glutaraldehyde-treated cells. I. Dissociation of immunological memory and antibody production.
    Ramos A; Zavala F; Hoecker G
    Immunology; 1979 Apr; 36(4):775-80. PubMed ID: 108207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dialysis procedure for loading erythrocytes with enzymes and lipids.
    Deloach J; Ihler G
    Biochim Biophys Acta; 1977 Jan; 496(1):136-45. PubMed ID: 836891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primaquine-induced hemolytic anemia: role of splenic macrophages in the fate of 5-hydroxyprimaquine-treated rat erythrocytes.
    Bowman ZS; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2005 Dec; 315(3):980-6. PubMed ID: 16099929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of erythrocyte physicochemical properties by millimolar concentrations of glutaraldehyde.
    Corry WD; Meiselman HJ
    Blood Cells; 1980; 6(1):93-5. PubMed ID: 6766073
    [No Abstract]   [Full Text] [Related]  

  • 38. Resistance to metabolic inactivation is a functional phenotype of radioresistant stimulating spleen cells (RSCs) in allo-CTL generation.
    Reme T; Cognot C; Dupuy d'Angeac A
    Immunology; 1985 Nov; 56(3):459-65. PubMed ID: 2934316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible binding of anthracycline antibiotics to erythrocytes treated with glutaraldehyde.
    Ataullakhanov FI; Kulikova EV; Vitvitsky VM
    Biotechnol Appl Biochem; 1996 Dec; 24(3):241-4. PubMed ID: 8969453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connective tissue reactions to acid glutaraldehyde.
    Martin H
    Oral Surg Oral Med Oral Pathol; 1978 Sep; 46(3):433-41. PubMed ID: 99708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.